(PTEN) Patterson-UTI Energy - Overview
Stock: Drilling, Completion, Bits, Motors, Wireline
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.27% |
| Yield on Cost 5y | 6.03% |
| Yield CAGR 5y | 41.42% |
| Payout Consistency | 87.7% |
| Payout Ratio | 213.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 42.9% |
| Relative Tail Risk | -6.64% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.22 |
| Alpha | -30.80 |
| Character TTM | |
|---|---|
| Beta | 1.948 |
| Beta Downside | 2.897 |
| Drawdowns 3y | |
|---|---|
| Max DD | 66.04% |
| CAGR/Max DD | -0.29 |
Description: PTEN Patterson-UTI Energy January 13, 2026
Patterson-UTI Energy Inc. (NASDAQ: PTEN) delivers drilling and completion services to oil and natural-gas producers through three operating segments: Drilling Services (contract and directional drilling, MWD, and related software), Completion Services (hydraulic fracturing, wireline, cementing, and ancillary power-logistics solutions), and Drilling Products (design, manufacture, and rental of polycrystalline-diamond-compact drill bits and other land-based tooling). The firm, founded in 1978 and based in Houston, also offers data-analytics tools such as HiFi Nav and HiFi Guidance that aim to improve well placement and trajectory optimization.
Key recent metrics indicate the company generated roughly $1.2 billion in revenue for Q4 2023, with an adjusted EBITDA margin near 15 %, reflecting the cyclical benefit of higher oil prices and a modestly rising on-shore rig count in the Permian and Eagle Ford basins. Capital expenditures have been focused on expanding its proprietary MWD platform and scaling the high-performance drill-bit product line, while the broader drilling sector remains sensitive to OPEC-plus production decisions and U.S. shale-drilling activity trends.
For a deeper, data-driven dive into PTEN’s valuation and risk profile, you may find the analytical tools on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -136.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -4.32 > 1.0 |
| NWC/Revenue: 10.33% < 20% (prev 7.65%; Δ 2.68% < -1%) |
| CFO/TA 0.16 > 3% & CFO 879.5m > Net Income -136.1m |
| Net Debt (1.10b) to EBITDA (907.1m): 1.22 < 3 |
| Current Ratio: 1.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (384.9m) vs 12m ago -1.75% < -2% |
| Gross Margin: 4.50% > 18% (prev 0.07%; Δ 442.7% > 0.5%) |
| Asset Turnover: 84.16% > 50% (prev 97.26%; Δ -13.10% > 0%) |
| Interest Coverage Ratio: -0.95 > 6 (EBITDA TTM 907.1m / Interest Expense TTM 70.6m) |
Altman Z'' -0.76
| A: 0.09 (Total Current Assets 1.28b - Total Current Liabilities 777.8m) / Total Assets 5.53b |
| B: -0.22 (Retained Earnings -1.22b / Total Assets 5.53b) |
| C: -0.01 (EBIT TTM -66.8m / Avg Total Assets 5.75b) |
| D: -0.53 (Book Value of Equity -1.21b / Total Liabilities 2.28b) |
| Altman-Z'' Score: -0.76 = CCC |
Beneish M -2.67
| DSRI: 1.11 (Receivables 861.0m/932.6m, Revenue 4.84b/5.80b) |
| GMI: 1.63 (GM 4.50% / 7.32%) |
| AQI: 1.02 (AQ_t 0.25 / AQ_t-1 0.25) |
| SGI: 0.83 (Revenue 4.84b / 5.80b) |
| TATA: -0.18 (NI -136.1m - CFO 879.5m) / TA 5.53b) |
| Beneish M-Score: -2.67 (Cap -4..+1) = A |
What is the price of PTEN shares?
Over the past week, the price has changed by +3.27%, over one month by +17.31%, over three months by +20.25% and over the past year by +1.48%.
Is PTEN a buy, sell or hold?
- StrongBuy: 5
- Buy: 5
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PTEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 7.3 | -4.2% |
| Analysts Target Price | 7.3 | -4.2% |
| ValueRay Target Price | 8.3 | 9.5% |
PTEN Fundamental Data Overview January 29, 2026
P/S = 0.5836
P/B = 0.8685
P/EG = 0.7785
Revenue TTM = 4.84b USD
EBIT TTM = -66.8m USD
EBITDA TTM = 907.1m USD
Long Term Debt = 1.22b USD (from longTermDebt, last quarter)
Short Term Debt = 32.6m USD (from shortTermDebt, last quarter)
Debt = 1.29b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.10b USD (from netDebt column, last quarter)
Enterprise Value = 3.93b USD (2.82b + Debt 1.29b - CCE 184.8m)
Interest Coverage Ratio = -0.95 (Ebit TTM -66.8m / Interest Expense TTM 70.6m)
EV/FCF = 13.60x (Enterprise Value 3.93b / FCF TTM 288.7m)
FCF Yield = 7.35% (FCF TTM 288.7m / Enterprise Value 3.93b)
FCF Margin = 5.97% (FCF TTM 288.7m / Revenue TTM 4.84b)
Net Margin = -2.81% (Net Income TTM -136.1m / Revenue TTM 4.84b)
Gross Margin = 4.50% ((Revenue TTM 4.84b - Cost of Revenue TTM 4.62b) / Revenue TTM)
Gross Margin QoQ = 4.81% (prev 2.14%)
Tobins Q-Ratio = 0.71 (Enterprise Value 3.93b / Total Assets 5.53b)
Interest Expense / Debt = 1.36% (Interest Expense 17.5m / Debt 1.29b)
Taxrate = 21.0% (US default 21%)
NOPAT = -52.8m (EBIT -66.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.64 (Total Current Assets 1.28b / Total Current Liabilities 777.8m)
Debt / Equity = 0.40 (Debt 1.29b / totalStockholderEquity, last quarter 3.25b)
Debt / EBITDA = 1.22 (Net Debt 1.10b / EBITDA 907.1m)
Debt / FCF = 3.82 (Net Debt 1.10b / FCF TTM 288.7m)
Total Stockholder Equity = 3.37b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.37% (Net Income -136.1m / Total Assets 5.53b)
RoE = -4.04% (Net Income TTM -136.1m / Total Stockholder Equity 3.37b)
RoCE = -1.45% (EBIT -66.8m / Capital Employed (Equity 3.37b + L.T.Debt 1.22b))
RoIC = -1.15% (negative operating profit) (NOPAT -52.8m / Invested Capital 4.59b)
WACC = 9.32% (E(2.82b)/V(4.11b) * Re(13.09%) + D(1.29b)/V(4.11b) * Rd(1.36%) * (1-Tc(0.21)))
Discount Rate = 13.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.13%
[DCF Debug] Terminal Value 71.21% ; FCFF base≈400.8m ; Y1≈355.6m ; Y5≈296.4m
Fair Price DCF = 8.35 (EV 4.27b - Net Debt 1.10b = Equity 3.17b / Shares 379.2m; r=9.32% [WACC]; 5y FCF grow -13.87% → 2.90% )
EPS Correlation: -34.69 | EPS CAGR: 1.43% | SUE: 0.14 | # QB: 0
Revenue Correlation: 84.54 | Revenue CAGR: 27.96% | SUE: 0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.11 | Chg30d=+0.003 | Revisions Net=+1 | Analysts=4
EPS next Year (2026-12-31): EPS=-0.37 | Chg30d=+0.017 | Revisions Net=+2 | Growth EPS=-17.4% | Growth Revenue=-5.5%